• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemokines in tumor progression and metastasis.趋化因子在肿瘤进展和转移中的作用
Oncotarget. 2013 Dec;4(12):2171-85. doi: 10.18632/oncotarget.1426.
2
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.超越细胞迁移:趋化因子及其受体在恶性肿瘤中的作用不断扩大。
Front Immunol. 2020 Jun 4;11:952. doi: 10.3389/fimmu.2020.00952. eCollection 2020.
3
Role of chemokines in tumor growth.趋化因子在肿瘤生长中的作用。
Cancer Lett. 2007 Oct 28;256(2):137-65. doi: 10.1016/j.canlet.2007.05.013. Epub 2007 Jul 12.
4
The chemokine network in cancer--much more than directing cell movement.癌症中的趋化因子网络——远不止于引导细胞移动。
Int J Dev Biol. 2004;48(5-6):489-96. doi: 10.1387/ijdb.041814hk.
5
Chemokines, chemokine receptors, and cancer metastasis.趋化因子、趋化因子受体与癌症转移
J Leukoc Biol. 2006 Apr;79(4):639-51. doi: 10.1189/jlb.1105633. Epub 2006 Feb 14.
6
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.趋化因子及其受体:肿瘤转移的协调者。
Int J Mol Sci. 2018 Dec 27;20(1):96. doi: 10.3390/ijms20010096.
7
Atypical chemokine receptors in tumor cell growth and metastasis.肿瘤细胞生长和转移中的非典型趋化因子受体。
Adv Cancer Res. 2020;145:1-27. doi: 10.1016/bs.acr.2019.12.002. Epub 2020 Jan 27.
8
Manipulating the chemokine-chemokine receptor network to treat cancer.通过调控趋化因子-趋化因子受体网络来治疗癌症。
Cancer. 2007 Jun 15;109(12):2392-404. doi: 10.1002/cncr.22706.
9
Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.趋化因子与癌症:微环境中的迁移、细胞内信号传导及细胞间通讯
Biochem J. 2008 Feb 1;409(3):635-49. doi: 10.1042/BJ20071493.
10
The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.非典型趋化因子受体在癌症中的多样且复杂的作用:从分子生物学到临床相关性和治疗。
Adv Cancer Res. 2020;145:99-138. doi: 10.1016/bs.acr.2019.12.001. Epub 2020 Feb 14.

引用本文的文献

1
The Prognostic Value of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Lung Cancer: A Systematic Review and Meta-Analysis.血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分在肺癌中的预后价值:一项系统评价和荟萃分析
J Clin Med. 2025 Aug 12;14(16):5701. doi: 10.3390/jcm14165701.
2
Chemokines: humble yet mighty players in the tumour microenvironment.趋化因子:肿瘤微环境中虽不起眼却强大的参与者。
Front Immunol. 2025 Aug 7;16:1601756. doi: 10.3389/fimmu.2025.1601756. eCollection 2025.
3
Gut modulation to regulate NF-κB in colorectal and gastric cancer therapy and inflammation.肠道调节在结直肠癌和胃癌治疗及炎症中对核因子-κB的调控作用
Cancer Immunol Immunother. 2025 Jul 12;74(8):264. doi: 10.1007/s00262-025-04118-9.
4
Augment proteasome inhibitor efficacy activates CD8 T cell-mediated antitumor immunity in breast cancer.增强蛋白酶体抑制剂疗效可激活乳腺癌中CD8 T细胞介导的抗肿瘤免疫。
Cell Rep Med. 2025 Jul 15;6(7):102211. doi: 10.1016/j.xcrm.2025.102211. Epub 2025 Jul 2.
5
Xanthatin nanocrystals exert anti-inflammatory properties against TNFα-primed 2D monolayers and in 3D spheroids of human HT29 colorectal cancer cells.山苍子油精纳米晶体对经肿瘤坏死因子α预处理的人HT29结肠癌细胞二维单层和三维球体具有抗炎特性。
Discov Nano. 2025 May 19;20(1):83. doi: 10.1186/s11671-025-04257-z.
6
Integrating multi-omics data to identify the role of Aggrephagy-related genes in tumor microenvironment and key tumorigenesis factors of GB from the perspective of single-cell sequencing.整合多组学数据,从单细胞测序的角度识别自噬相关基因在肿瘤微环境中的作用以及胶质母细胞瘤的关键肿瘤发生因素。
Discov Oncol. 2025 May 16;16(1):777. doi: 10.1007/s12672-025-02431-4.
7
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions.癌症免疫疗法的进展:历史回顾、当前发展及未来方向。
Mol Cancer. 2025 May 7;24(1):136. doi: 10.1186/s12943-025-02305-x.
8
Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.胶质母细胞瘤复发的远处起源:脑室下区的神经干细胞是原发性切除术后肿瘤重建的来源。
Mol Cancer. 2025 Mar 4;24(1):64. doi: 10.1186/s12943-025-02273-2.
9
Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration.内体趋化因子受体信号体调节细胞迁移的核心机制。
Elife. 2025 Feb 24;13:RP99373. doi: 10.7554/eLife.99373.
10
The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.趋化因子系统作为肺纤维化的关键调节因子:人类特发性肺纤维化(IPF)与博来霉素诱导的小鼠肺纤维化模型中的共同通路
Cells. 2024 Dec 12;13(24):2058. doi: 10.3390/cells13242058.

本文引用的文献

1
The role of CXCR3 and CXCR4 in colorectal cancer metastasis.CXCR3 和 CXCR4 在结直肠癌转移中的作用。
Int J Cancer. 2013 Jan 15;132(2):276-87. doi: 10.1002/ijc.27670. Epub 2012 Jul 3.
2
Role of chemokine receptor CXCR7 in bladder cancer progression.趋化因子受体 CXCR7 在膀胱癌进展中的作用。
Biochem Pharmacol. 2012 Jul 15;84(2):204-14. doi: 10.1016/j.bcp.2012.04.007. Epub 2012 Apr 13.
3
CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases.CXCR4 和 CXCL12 的免疫反应可区分有无脑转移的原发性非小细胞肺癌。
Cancer Biomark. 2011;10(2):79-89. doi: 10.3233/CBM-2011-0232.
4
CXCR4 expression in prostate cancer progenitor cells.前列腺癌细胞祖细胞中的 CXCR4 表达。
PLoS One. 2012;7(2):e31226. doi: 10.1371/journal.pone.0031226. Epub 2012 Feb 16.
5
Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.解析 CCR2-CCL2 轴在肿瘤存活和血管生成中的自分泌和旁分泌作用。
PLoS One. 2012;7(1):e28305. doi: 10.1371/journal.pone.0028305. Epub 2012 Jan 18.
6
Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN).趋化因子受体 7(CCR7)基因的表达受 NF-κB 和激活蛋白 1(AP1)在头颈部转移性鳞状细胞癌(SCCHN)中的调控。
J Biol Chem. 2012 Jan 27;287(5):3581-90. doi: 10.1074/jbc.M111.294876. Epub 2011 Dec 12.
7
Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer.趋化因子受体CXCR4表达与前列腺癌患者预后因素的相关性
Korean J Urol. 2011 Sep;52(9):607-11. doi: 10.4111/kju.2011.52.9.607. Epub 2011 Sep 28.
8
Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.CCR7 表达缺失是胰腺导管腺癌淋巴扩散的限制因素。
Int J Cancer. 2012 Aug 15;131(4):E371-81. doi: 10.1002/ijc.26502. Epub 2012 Jan 11.
9
Homeostatic chemokine receptors and organ-specific metastasis.稳态趋化因子受体与器官特异性转移。
Nat Rev Immunol. 2011 Aug 25;11(9):597-606. doi: 10.1038/nri3049.
10
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.CXCR1 和 CXCR2 的沉默调节 CXCL8 依赖性内皮细胞增殖、迁移和毛细血管样结构形成。
Microvasc Res. 2011 Nov;82(3):318-25. doi: 10.1016/j.mvr.2011.06.011. Epub 2011 Jul 1.

趋化因子在肿瘤进展和转移中的作用

Chemokines in tumor progression and metastasis.

作者信息

Sarvaiya Purvaba J, Guo Donna, Ulasov Ilya, Gabikian Patrik, Lesniak Maciej S

机构信息

The Brain Tumor Center, The University of Chicago, Chicago, Illinois, USA.

出版信息

Oncotarget. 2013 Dec;4(12):2171-85. doi: 10.18632/oncotarget.1426.

DOI:10.18632/oncotarget.1426
PMID:24259307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3926818/
Abstract

Chemokines play a vital role in tumor progression and metastasis. Chemokines are involved in the growth of many cancers including breast cancer, ovarian cancer, pancreatic cancer, melanoma, lung cancer, gastric cancer, acute lymphoblastic leukemia, colon cancer, non-small lung cancer, non-hodgkin's lymphoma, etc. The expression of chemokines and their receptors is altered in many malignancies and leads to aberrant chemokine receptor signaling. This review focuses on the role of chemokines in key processes that facilitate tumor progression including proliferation, senescence, angiogenesis, epithelial mesenchymal transition, immune evasion and metastasis.

摘要

趋化因子在肿瘤进展和转移中起着至关重要的作用。趋化因子参与多种癌症的生长,包括乳腺癌、卵巢癌、胰腺癌、黑色素瘤、肺癌、胃癌、急性淋巴细胞白血病、结肠癌、非小细胞肺癌、非霍奇金淋巴瘤等。趋化因子及其受体的表达在许多恶性肿瘤中发生改变,并导致趋化因子受体信号异常。本综述重点关注趋化因子在促进肿瘤进展的关键过程中的作用,包括增殖、衰老、血管生成、上皮-间质转化、免疫逃逸和转移。